Juno Therapeutics Inc. (JUNO)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q4 2017 | |||||
| ≡ | Meridian Contrarian Fund | Add 1806533.33% | 216,784 | 1.62 | |
| Q1 2017 | |||||
| ≡ | Meridian Contrarian Fund | Add 58.63% | 93,062 | 0.40 | |
| Q4 2016 | |||||
| ≡ | Meridian Contrarian Fund | Add 55.25% | 56,492 | 0.20 | |
| Q3 2016 | |||||
| ≡ | Meridian Contrarian Fund | Buy | 102,242 | 0.60 | |
| Q4 2014 | |||||
| ≡ | Leon Cooperman | Buy | 50,000 | 0.04 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.